Carolina Correa takes over the management of Amgen Deutschland GmbH
11.09.2025 18:16
Effective September 1, 2025, Carolina Correa took over the management of Amgen Deutschland GmbH from Manfred Heinzer, who had previously successfully led the German national organization for five years.
Carolina Correa is an internationally experienced leader with more than 20 years of industry experience in senior positions at global pharmaceutical and biotechnology companies, including Incyte, AbbVie, Novartis, and Merck. Since 2022, she has led Amgen's national organization in the Netherlands, which, under her leadership, has continuously improved patient reach and successfully launched important therapies.
Correa was born in Argentina and previously worked in Germany. A personal experience had a particularly profound impact on her career: At the age of 16, Correa was diagnosed with acute leukemia, which she successfully battled. This life-changing experience had a lasting impact on her passion for healthcare and continues to drive her to this day.
Correa explains: "I am very much looking forward to taking over the management of Amgen Deutschland GmbH. My personal history has shown me how crucial innovations can be in medicine. Together with our strong team here in Germany, I will do everything in my power to further expand access to innovative therapies and improve the lives of patients and
to sustainably improve patient care.”